Sudarshan Chemical sells VP4 Frankfurt stake to Celanese for EUR 76.5 million
- Sudarshan Chemical Industries sells VP4 Frankfurt GmbH to Celanese US Holdings LLC for EUR 76.5 million
- Transaction finalized on August 31, 2026, to sharpen focus on core pigment business
- VP4 Frankfurt contributed EUR 15.7 million in revenue, or 1.64% of consolidated revenue, as of March 31, 2026
- Buyer Celanese is not related to the promoter group; deal subject to customary closing conditions
*this image is generated using AI for illustrative purposes only.
Sudarshan Chemical Industries has signed a definitive agreement to sell its entire stake in VP4 Frankfurt GmbH to Celanese US Holdings LLC for EUR 76.5 million. The transaction, finalized on August 31, 2026, marks a strategic step toward sharpening the company’s focus on its core pigment business.
VP4 Frankfurt, a wholly-owned subsidiary of Sudarshan Germany Horizons GmbH, operates primarily as a tolling manufacturer of intermediates. Only a small portion of its output is consumed captive by Sudarshan Germany Horizons. The buyer, Celanese US Holdings LLC, is part of Celanese Corporation, a global chemical and specialty materials company, and is not related to the promoter group.
Transaction Details
The sale is structured as a share purchase and transfer agreement. Completion is subject to the fulfillment of customary closing conditions and other precedents. The transaction falls outside the purview of related-party transactions and is not part of any scheme of arrangement. Consequently, Regulation 37A of the SEBI Listing Regulations, 2015, is not applicable.
| Particulars | Details |
|---|---|
| Buyer | Celanese US Holdings LLC |
| Consideration | EUR 76.5 million |
| Date of Agreement | August 31, 2026 |
| Status | Subject to closing conditions |
Strategic Rationale
VP4 Frankfurt became part of Sudarshan through its acquisition of the Heubach Group. It serves Nutrinova, an affiliate of Celanese Corporation and Mitsui & Co. Japan, as its principal customer. Diketene, a key intermediate produced by VP4, is important for functional food ingredients. This makes the asset a stronger strategic fit with Celanese and Nutrinova, a producer of additives for the food industry such as sweeteners.
The transaction places VP4 Frankfurt more closely aligned with its principal customer. Following completion, Nutrinova will continue to supply Sudarshan with the materials it requires.
"The sale of VP4 Frankfurt is a strategic step in sharpening our focus. Pigments and colorants are where we create the most value for our customers. VP4 is a well-run business with a strong team, and it now moves to the company it already serves. That is the right outcome for the asset, for its employees, and for Sudarshan," said Rajesh Rathi, Chairman & Managing Director, Sudarshan Chemical Industries Limited.
Financial Impact
As of March 31, 2026, VP4 Frankfurt contributed EUR 15.7 million in revenue, accounting for 1.64% of Sudarshan Chemical Industries’ consolidated revenue and 6.71% of its standalone revenue. The net worth contribution of the unit stood at EUR 5.7 million.
What the Numbers Show
The consideration of EUR 76.5 million represents a significant premium over the subsidiary’s net worth contribution of EUR 5.7 million as of March 31, 2026. This valuation gap suggests the price reflects future cash flow expectations or strategic value to the buyer rather than just book value. Additionally, while the unit contributes nearly double its weight to standalone revenue (6.71%) compared to consolidated revenue (1.64%), its small share of total consolidated output indicates limited operational dependency for the broader group.
The company disclosed this transaction under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed with BSE Limited and the National Stock Exchange of India Limited on September 1, 2026.
Historical Stock Returns for Sudarshan Chemical Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.79% | +4.25% | +22.71% | +44.39% | -15.56% | 0.0% |
How will the EUR 76.5 million proceeds from the VP4 Frankfurt sale be allocated, and will Sudarshan Chemical prioritize debt reduction, share buybacks, or reinvestment in core pigment capacity expansion?
Given that VP4 Frankfurt contributed 6.71% of standalone revenue, what specific operational adjustments or cost-saving measures will Sudarshan implement to offset this loss in its non-consolidated financials?
Will the strategic shift toward focusing exclusively on pigments and colorants lead to further divestitures of non-core assets in the coming fiscal years?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
